Sign in or Register   Sign in or Register
  |  

Mouse Anti-DCPS Recombinant Antibody (3E5) (CBMAB-D0392-YC)

Provided herein is a Mouse monoclonal antibody, which binds to Decapping Enzyme, Scavenger (DCPS). The antibody can be used for immunoassay techniques, such as WB.
See all DCPS antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
3E5
Antibody Isotype
IgG2a, κ
Application
WB

Basic Information

Immunogen
DCPS (AAH14532, 1 a.a. ~ 338 a.a) full length recombinant protein with GST tag.
Specificity
Human
Antibody Isotype
IgG2a, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
decapping enzyme, scavenger
Introduction
DCPS belongs to the histidine triad family of pyrophosphatases that removes short mRNA fragments containing the 5′ mRNA cap structure, which appear in the 3′ → 5′ mRNA decay pathway, following deadenylation and exosome-mediated turnover. This enzyme hydrolyzes the triphosphate linkage of the cap structure (7-methylguanosine nucleoside triphosphate) to yield 7-methylguanosine monophosphate and nucleoside diphosphate. It protects the cell from the potentially toxic accumulation of these short, capped mRNA fragments, and regulates the activity of other cap-binding proteins, which are inhibited by their accumulation. It also acts as a transcript-specific modulator of pre-mRNA splicing and microRNA turnover.
Entrez Gene ID
28960
UniProt ID
Q96C86
Alternative Names
Decapping Enzyme, Scavenger; 5-(N(7)-Methyl 5-Triphosphoguanosine)-[MRNA] Diphosphatase; Histidine Triad Nucleotide-Binding Protein 5; Hint-Related 7meGMP-Directed Hydrolase; Scavenger MRNA-Decapping Enzyme DcpS; Histidine Triad Protein Member 5; Decapping Scavenger Enzyme; HINT-5; HINT5; DCS1;
Function
Decapping scavenger enzyme that catalyzes the cleavage of a residual cap structure following the degradation of mRNAs by the 3'->5' exosome-mediated mRNA decay pathway. Hydrolyzes cap analog structures like 7-methylguanosine nucleoside triphosphate (m7GpppG) with up to 10 nucleotide substrates (small capped oligoribonucleotides) and specifically releases 5'-phosphorylated RNA fragments and 7-methylguanosine monophosphate (m7GMP). Cleaves cap analog structures like tri-methyl guanosine nucleoside triphosphate (m3(2,2,7)GpppG) with very poor efficiency. Does not hydrolyze unmethylated cap analog (GpppG) and shows no decapping activity on intact m7GpppG-capped mRNA molecules longer than 25 nucleotides. Does not hydrolyze 7-methylguanosine diphosphate (m7GDP) to m7GMP (PubMed:22985415).

May also play a role in the 5'->3 mRNA decay pathway; m7GDP, the downstream product released by the 5'->3' mRNA mediated decapping activity, may be also converted by DCPS to m7GMP (PubMed:14523240).

Binds to m7GpppG and strongly to m7GDP. Plays a role in first intron splicing of pre-mRNAs. Inhibits activation-induced cell death.
Biological Process
Cellular response to menadione Source: UniProtKB
Deadenylation-dependent decapping of nuclear-transcribed mRNA Source: GO_Central
Exonucleolytic catabolism of deadenylated mRNA Source: Reactome
mRNA cis splicing, via spliceosome Source: UniProtKB
Negative regulation of programmed cell death Source: UniProtKB
Nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay Source: UniProtKB
Cellular Location
Cytoplasm; Nucleus. Predominantly localized in the nucleus. Nucleocytoplasmic shuttling protein that can transiently enter the cytoplasm in mammalian cells in a XPO1/CRM1-dependent manner.
Involvement in disease
Al-Raqad syndrome (ARS):
A syndrome characterized by delayed psychomotor development, moderate to severe intellectual disability, poor or absent speech, microcephaly, congenital hypotonia, and severe growth delay.

Salamon, I., Palsule, G., Luo, X., Roque, A., Tucai, S., Khosla, I., ... & Kiledjian, M. (2022). mRNA-decapping associated DcpS enzyme controls critical steps of neuronal development. Cerebral Cortex, 32(7), 1494-1507.

Fuchs, A. L., Wurm, J. P., Neu, A., & Sprangers, R. (2020). Molecular basis of the selective processing of short mRNA substrates by the DcpS mRNA decapping enzyme. Proceedings of the National Academy of Sciences, 117(32), 19237-19244.

Ferenc-Mrozek, A., Bojarska, E., Stepinski, J., Darzynkiewicz, E., & Lukaszewicz, M. (2020). Effect of the His-tag location on decapping scavenger enzymes and their hydrolytic activity toward cap analogs. ACS omega, 5(19), 10759-10766.

Wulf, M. G., Buswell, J., Chan, S. H., Dai, N., Marks, K., Martin, E. R., ... & Schildkraut, I. (2019). The yeast scavenger decapping enzyme DcpS and its application for in vitro RNA recapping. Scientific reports, 9(1), 1-9.

Mei, Z. Z., Sun, H., Ou, X., Li, L., Cai, J., Hu, S., ... & Jiang, Y. (2019). The natural antisense transcript NATTD regulates the transcription of decapping scavenger (DcpS) enzyme. The International Journal of Biochemistry & Cell Biology, 110, 103-110.

Pietrow, P., Ferenc-Mrozek, A., Piecyk, K., Bojarska, E., Darzynkiewicz, E., & Jankowska-Anyszka, M. (2019). Decapping Scavenger Enzyme Activity toward N2-Substituted 5′ End mRNA Cap Analogues. ACS omega, 4(17), 17576-17580.

Yamauchi, T., Masuda, T., Canver, M. C., Seiler, M., Semba, Y., Shboul, M., ... & Maeda, T. (2018). Genome-wide CRISPR-Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS. Cancer cell, 33(3), 386-400.

Cherry, J. J., DiDonato, C. J., Androphy, E. J., Calo, A., Potter, K., Custer, S. K., ... & Tones, M. A. (2017). In vitro and in vivo effects of 2, 4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: context-specific modulation of SMN transcript levels. PloS one, 12(9), e0185079.

Gopalsamy, A., Narayanan, A., Liu, S., Parikh, M. D., Kyne Jr, R. E., Fadeyi, O., ... & Jones, L. H. (2017). Design of potent mRNA decapping scavenger enzyme (DcpS) inhibitors with improved physicochemical properties to investigate the mechanism of therapeutic benefit in spinal muscular atrophy (SMA). Journal of medicinal chemistry, 60(7), 3094-3108.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-DCPS Recombinant Antibody (3E5)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare